We are live on
!
Find out more
Boston Partners Portfolio holdings
AUM
$113B
1-Year Est. Return
38.87%
This Fund
S&P 500
This Quarter
Est. Return
+4.08%
1 Year Est. Return
+38.87%
3 Year Est. Return
+108.29%
5 Year Est. Return
+142.95%
10 Year Est. Return
+500.61%
AUM
$95.5B
AUM Growth
-$1.12B
(-1.2%)
Cap. Flow
-$1.59B
Cap. Flow
% of AUM
-1.66%
Top 10 Holdings %
Top 10 Hldgs %
13.57%
Holding
857
New
106
Increased
293
Reduced
358
Closed
90
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Booking.com
BKNG
|
+$836M |
| 2 |
Marvell Technology
MRVL
|
+$518M |
| 3 |
Visa
V
|
+$461M |
| 4 |
NVIDIA
NVDA
|
+$307M |
| 5 |
McCormick & Company Non-Voting
MKC
|
+$281M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$483M |
| 2 |
Medtronic
MDT
|
+$451M |
| 3 |
AutoZone
AZO
|
+$361M |
| 4 |
Carlyle Group
CG
|
+$327M |
| 5 |
Keysight
KEYS
|
+$306M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.21% |
| 2 | Technology | 16.01% |
| 3 | Industrials | 14.55% |
| 4 | Healthcare | 11.39% |
| 5 | Consumer Discretionary | 9.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Vistra
VST
$47.6B
| $2.46M | ﹤0.01% |
16,366
+1,080
| +7% | +$175K |
|
552
Banco Bilbao Vizcaya Argentaria
BBVA
$155B
| $2.44M | ﹤0.01% |
112,718
-107,769
| -49% | -$2.49M |
|
553
Hanover Insurance
THG
$7.96B
| $2.43M | ﹤0.01% |
14,034
+712
| +5% | +$124K |
|
554
Celestica
CLS
$42.4B
| $2.39M | ﹤0.01% |
8,500
+4
| +0% | +$1.16K |
|
555
Atlas Energy Solutions
AESI
$1.35B
| $2.36M | ﹤0.01% |
179,765
-26,402
| -13% | -$308K |
|
556
AutoNation
AN
$7.1B
| $2.35M | ﹤0.01% |
12,056
-990,754
| -99% | -$200M |
|
557
AMERISAFE
AMSF
$556M
| $2.35M | ﹤0.01% |
70,437
+3,002
| +4% | +$108K |
|
558
Carrier Global
CARR
$54B
| $2.33M | ﹤0.01% |
41,361
+2,320
| +6% | +$137K |
|
|
VG
559
Venture Global Inc
VG
$31B
| $2.29M | ﹤0.01% |
+145,581
| New | +$1.56M |
|
560
Canadian Pacific Kansas City
CP
$80.6B
| $2.29M | ﹤0.01% |
29,130
+4,894
| +20% | +$387K |
|
561
Bio-Rad Laboratories Class A
BIO
$9.17B
| $2.28M | ﹤0.01% |
8,193
-239,419
| -97% | -$69M |
|
562
American Superconductor
AMSC
$1.6B
| $2.24M | ﹤0.01% |
+66,071
| New | +$2.09M |
|
563
Progressive
PGR
$123B
| $2.23M | ﹤0.01% |
11,272
+1,100
| +11% | +$227K |
|
564
Lazard
LAZ
$4.27B
| $2.22M | ﹤0.01% |
+52,320
| New | +$2.56M |
|
565
ManpowerGroup
MAN
$2.53B
| $2.21M | ﹤0.01% |
+75,082
| New | +$2.23M |
|
566
Pan American Silver
PAAS
$20.2B
| $2.21M | ﹤0.01% |
40,427
+1,702
| +4% | +$98.1K |
|
567
Century Communities
CCS
$2.04B
| $2.18M | ﹤0.01% |
37,993
+9,136
| +32% | +$588K |
|
568
COPT Defense Properties
CDP
$4.23B
| $2.17M | ﹤0.01% |
71,007
+4,678
| +7% | +$146K |
|
569
Takeda Pharmaceutical
TAK
$52.9B
| $2.14M | ﹤0.01% |
115,522
+21,812
| +23% | +$383K |
|
570
Fidelity Investment Grade Bond ETF
FIGB
$521M
| $2.13M | ﹤0.01% |
49,317
+4,759
| +11% | +$207K |
|
571
Post Holdings
POST
$4.03B
| $2.12M | ﹤0.01% |
+21,465
| New | +$2.19M |
|
572
Apple
AAPL
$4.52T
| $2.1M | ﹤0.01% |
8,292
+315
| +4% | +$82K |
|
573
Sonoco
SON
$5.77B
| $2.1M | ﹤0.01% |
38,841
-12,943
| -25% | -$667K |
|
574
iShares 1-3 Year Treasury Bond ETF
SHY
$25.1B
| $2.04M | ﹤0.01% |
24,759
+3,153
| +15% | +$261K |
|
575
NextEra Energy
NEE
$179B
| $2.04M | ﹤0.01% |
21,927
+329
| +2% | +$29.3K |
|
Similar funds
Boston Partners's Q1 2026 Portfolio in Review
As of Q1 2026, Boston Partners held 857 positions worth $95.5B, down 1.2% from $96.6B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Boston Partners's Q1 2026 filing shows 106 new, 293 increased, 358 reduced and 90 closed positions. Its largest new stake was Marvell Technology: 6,165,682 shares worth $613M. The largest sale was UnitedHealth, an estimated $483M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 21% a quarter earlier, followed by Technology and Industrials.
- Boston Partners's largest Q1 2026 buy was Marvell Technology: 6,165,682 shares worth $613M.
- Boston Partners added most to Booking.com in Q1 2026, an estimated $836M increase.
- Boston Partners's biggest Q1 2026 reduction was UnitedHealth, cutting an estimated $483M.
- Boston Partners fully exited Carlyle Group in Q1 2026, selling an estimated $327M.
- Boston Partners's ten largest holdings make up 14% of its $95.5B portfolio in Q1 2026.
- Boston Partners opened 106 new positions and closed 90 in Q1 2026.
- Boston Partners's portfolio value fell 1.2% quarter-over-quarter to $95.5B.
Based on Boston Partners's 13F filing for Q1 2026, filed 11 May 2026.